Angelelli B - Search Results

1

Oxaliplatin plus raltitrexed in the treatment of patients with advanced colorectal cancer: a phase II study.

Martoni A, Mini E, Pinto C, Gentile AL, Nobili S, Dentico P, Marino A, Scicolone S, Angelelli B, Mazzei T. Martoni A, et al. Among authors: angelelli b. Anticancer Res. 2003 Jan-Feb;23(1B):687-91. Anticancer Res. 2003. PMID: 12680168 Clinical Trial.

2

Pilot study on induction chemotherapy with cisplatin, epirubicin, etoposide and bleomycin in cervical cancer stage Ib, IIa and IIb.

Panetta A, Angelelli B, Martoni A. Panetta A, et al. Among authors: angelelli b. Anticancer Res. 1999 Jan-Feb;19(1B):765-8. Anticancer Res. 1999. PMID: 10216490 Clinical Trial.

3

Oxaliplatin and protracted continuous 5-fluorouracil infusion in patients with pretreated advanced colorectal carcinoma.

Martoni A, Mini E, Pinto C, Nobili S, Gentile AL, Dentico P, Angelelli B, Scicolone S, Piana E, Mazzei T. Martoni A, et al. Among authors: angelelli b. Ann Oncol. 2001 Apr;12(4):519-24. doi: 10.1023/a:1011103213297. Ann Oncol. 2001. PMID: 11398887 Free article. Clinical Trial.

4

A phase II study of carboplatin and cyclophosphamide in advanced ovarian carcinoma.

Martoni A, Panetta A, Angelelli B, Melotti B, Pannuti F. Martoni A, et al. Among authors: angelelli b. J Chemother. 1993 Feb;5(1):47-51. doi: 10.1080/1120009x.1993.11739209. J Chemother. 1993. PMID: 8459265 Clinical Trial.

5

Chemotherapy of advanced ovarian cancer.

Martoni A, Cacciari N, Angelelli B, Zamagni C, Pannuti F. Martoni A, et al. Among authors: angelelli b. Front Biosci. 1997 Mar 15;2:g20-6. Front Biosci. 1997. PMID: 9159262

6

Multimodal sequential approach in colorectal cancer liver metastases: hepatic resection after yttrium-90 selective internal radiation therapy and cetuximab rescue treatment.

Pini S, Pinto C, Angelelli B, Giampalma E, Blotta A, Di Fabio F, Santini D, Golfieri R, Martoni AA. Pini S, et al. Among authors: angelelli b. Tumori. 2010 Jan-Feb;96(1):157-9. doi: 10.1177/030089161009600126. Tumori. 2010. PMID: 20437875

7

An open randomised cross-over study on granisetron versus ondansetron in the prevention of acute emesis induced by moderate dose cisplatin-containing regimens.

Martoni A, Angelelli B, Guaraldi M, Strocchi E, Pannuti F. Martoni A, et al. Among authors: angelelli b. Eur J Cancer. 1996 Jan;32A(1):82-5. doi: 10.1016/0959-8049(95)00519-6. Eur J Cancer. 1996. PMID: 8695248 Clinical Trial.

8

Comparative crossover trial of two intravenous doses of granisetron (1 mg vs 3 mg) + dexamethasone in the prevention of acute cis-platinum-induced emesis.

Martoni A, Piana E, Strocchi E, Angelelli B, Guaraldi M, Zamagni C, Camaggi CM, Pannuti F. Martoni A, et al. Among authors: angelelli b. Anticancer Res. 1998 Jul-Aug;18(4B):2799-803. Anticancer Res. 1998. PMID: 9713464 Clinical Trial.

9

A new six-drug antiblastic regimen (R 14) at low doses (micropolychemotherapy) compared to CMF in the treatment of metastatic breast cancer: phase III study.

Pannuti F, Iafelice G, Martoni A, Fruet F, Angelelli B, Casadei M. Pannuti F, et al. Among authors: angelelli b. Chemioterapia. 1984 Aug;3(4):216-9. Chemioterapia. 1984. PMID: 6398121 Clinical Trial.

10

CD44 isoform 6 (CD44v6) is a prognostic indicator of the response to neoadjuvant chemotherapy in cervical carcinoma.

Costa S, Terzano P, Bovicelli A, Martoni A, Angelelli B, Santini D, Ceccarelli C, Lipponen P, Erzén M, Syrjänen S, Syrjänen K. Costa S, et al. Among authors: angelelli b. Gynecol Oncol. 2001 Jan;80(1):67-73. doi: 10.1006/gyno.2000.6016. Gynecol Oncol. 2001. PMID: 11136572 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29 results

Search Page

Filters